Théa and Olix Pharmaceuticals sign a new partnership
Thea2023-04-07T15:35:30+02:00Théa and Olix Pharmaceuticals sign a new partnership
Théa and Olix Pharmaceuticals sign a new partnership
Théa and Gallimedix, Inc sign a new partnership
Théa Open Innovation and CURACLE sign a new partnership
Théa and Coave Therapeutics announce their partnership
Théa and Coave Therapeutics announce their partnership
Théa and Coave Therapeutics sign an exclusive licensing, co development and commercialization agreement
Théa and Coave Therapeutics announce their partnership
Théa Open Innovation signs an exclusive Licensing Agreement for the rights on Ripple Therapeutics Corporation lead product, IBE-814 for North America and Europe.
EVEON, designer and maker of medical devices for the preparation and administration of drugs, and Théa, European leader in the field of ophthalmology, announce their partnership in the development of innovative medical technologies.
OliX Pharmaceuticals Announces Expansion of Collaboration with Laboratoires Théa to Develop siRNA Therapeutics for Ophthalmic Diseases.
Cookie | Type | Duration | Description |
---|---|---|---|
cookielawinfo-checkbox-necessary | 0 | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-non-necessary | 0 | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Non Necessary". |
viewed_cookie_policy | 0 | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Cookie | Type | Duration | Description |
---|---|---|---|
_ga | third party | 2 years | Used to distinguish users. |
Cookie | Type | Duration | Description |
---|---|---|---|
_icl_current_language | session | 10 days | Stores the redirected language. |